CLOV (Clover Health Investments) Beneish M-Score: -2.71 (As of Jun. 24, 2026)


CLOV Clover Health Investments Corp CLOV
81 GF Score
Price $5.13
GF Value $3.95
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clover Health Investments Beneish M-Score?

Clover Health Investments CLOV +1.58% 81 Beneish M-Score is -2.71 as of Jun. 24, 2026. GuruFocus rates CLOV with a GF Score™ of 81/100 and a GF Value™ of $3.95 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 18 Healthcare Plans companies, Clover Health Investments ranks better than 55.56% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.71 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Clover Health Investments's Beneish M-Score or its related term are showing as below:

CLOV' s Beneish M-Score Range Over the Past 10 Years
Min: -15.87   Med: -2.02   Max: 91.23
Current: -2.71

During the past 7 years, the highest Beneish M-Score of Clover Health Investments was 91.23. The lowest was -15.87. And the median was -2.02.


Clover Health Investments Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments Beneish M-Score Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -5.33 -3.65 -3.39 -2.73 -1.81

Clover Health Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.09 -1.94 -1.66 -1.81 -2.71

CLOV vs PGNY, ALHC, PFHO: Beneish M-Score Comparison

For the Healthcare Plans subindustry, Clover Health Investments's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clover Health Investments Beneish M-Score vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's Beneish M-Score falls into.


CLOV
81GF Score
Clover Health Investments Corp CLOV
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Health Investments Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Clover Health Investments for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9856+0.528 * 1.434+0.404 * 0.8214+0.892 * 1.4875+0.115 * 1.1321
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7483+4.679 * -0.163638-0.327 * 1.3057
=-2.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $203 Mil.
Revenue was 749.189 + 487.707 + 496.65 + 477.62 = $2,211 Mil.
Gross Profit was 159.541 + 74.208 + 73.177 + 99.628 = $407 Mil.
Total Current Assets was $448 Mil.
Total Assets was $698 Mil.
Property, Plant and Equipment(Net PPE) was $7 Mil.
Depreciation, Depletion and Amortization(DDA) was $2 Mil.
Selling, General, & Admin. Expense(SGA) was $462 Mil.
Total Current Liabilities was $337 Mil.
Long-Term Debt & Capital Lease Obligation was $0 Mil.
Net Income was 27.334 + -49.32 + -24.377 + -10.578 = $-57 Mil.
Non Operating Income was 0 + -0.001 + 0 + -0.019 = $-0 Mil.
Cash Flow from Operations was 107.895 + -68.152 + 12.103 + 5.408 = $57 Mil.
Total Receivables was $138 Mil.
Revenue was 462.331 + 336.963 + 330.986 + 356.26 = $1,487 Mil.
Gross Profit was 108.889 + 93.919 + 81.212 + 107.913 = $392 Mil.
Total Current Assets was $331 Mil.
Total Assets was $584 Mil.
Property, Plant and Equipment(Net PPE) was $5 Mil.
Depreciation, Depletion and Amortization(DDA) was $1 Mil.
Selling, General, & Admin. Expense(SGA) was $415 Mil.
Total Current Liabilities was $216 Mil.
Long-Term Debt & Capital Lease Obligation was $0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(202.689 / 2211.166) / (138.256 / 1486.54)
=0.091666 / 0.093005
=0.9856

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(391.933 / 1486.54) / (406.554 / 2211.166)
=0.263655 / 0.183864
=1.434

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (448.021 + 6.904) / 697.728) / (1 - (331.409 + 5.026) / 583.717)
=0.347991 / 0.423633
=0.8214

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2211.166 / 1486.54
=1.4875

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.479 / (1.479 + 5.026)) / (1.735 / (1.735 + 6.904))
=0.227364 / 0.200833
=1.1321

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(461.74 / 2211.166) / (414.839 / 1486.54)
=0.208822 / 0.279063
=0.7483

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 336.583) / 697.728) / ((0 + 215.653) / 583.717)
=0.482399 / 0.369448
=1.3057

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-56.941 - -0.02 - 57.254) / 697.728
=-0.163638

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Clover Health Investments has a M-score of -2.71 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.71 mean?
Clover Health Investments (CLOV) has a Beneish M-Score of -2.71 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Clover Health Investments and its competitors. According to the industry distribution chart, Clover Health Investments ranks #8 out of 18 companies in the Healthcare Plans industry, placing it in the top 44.4%.
Is Clover Health Investments' Beneish M-Score too high?
Clover Health Investments' current Beneish M-Score is -2.71. Based on the distribution chart, Clover Health Investments ranks #8 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Clover Health Investments has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Beneish M-Score compare to PGNY and ALHC?
According to the Healthcare Plans industry distribution chart, Clover Health Investments ranks #8 out of 18 companies for Beneish M-Score. This puts Clover Health Investments in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Plans company?
A good Beneish M-Score depends on the Healthcare Plans industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Clover Health Investments and its competitors. Clover Health Investments's current Beneish M-Score is -2.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.95, compared to a current price of $5.13 — trading 29.9% above its estimated fair value. The current Beneish M-Score is -2.71. Clover Health Investments' overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current Beneish M-Score is -2.71 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $5.13 is trading 29.9% above its estimated GF Value™ of $3.95. GuruFocus considers Clover Health Investments to be Modestly Overvalued.

Key valuation signals for CLOV:

  • Beneish M-Score: -2.71
  • GF Value™: $3.95 vs. price of $5.13 (29.9% above fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clover Health Investments Business Description

Other Exchanges 7QD:GermanyCLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
81GF Score

Get the complete analysis for CLOV

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.13
Price
$3.95
GF Value